NIH Guide: Weekly Index for November 5, 2021

Funding Opportunities

• Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional)
  (PAR-22-053)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): November 5, 2024
• Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
  (PAR-22-054)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): February 23, 2022
• Limited Competition: Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)
  (PAR-22-056)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): September 25, 2022
• Prodromal Synaptic and Circuit Changes that Contribute to AD/ADRD Onset and Progression (R01 Clinical Trial Not Allowed)
  (PAR-22-059)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): February 5, 2022
• Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)
  (PAR-22-061)
  National Cancer Institute
  Application Receipt Date(s): January 7, 2025
• Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)
  (PAR-22-062)
  National Cancer Institute
  Application Receipt Date(s): January 7, 2025
• Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
  (RFA-AG-22-026)
  National Institute on Aging
  Application Receipt Date(s): October 22, 2021
• RePORT International Coordinating Center (RICC) (U01 Clinical Trial Not Allowed)
  (RFA-AI-21-078)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): March 17, 2022
• NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
  (RFA-CA-21-060)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2022
• NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
  (RFA-CA-21-061)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2022 No late applications will be accepted for this Funding Opportunity Announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
  (RFA-CA-21-062)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2022
• Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
  (RFA-CA-22-003)
  National Cancer Institute
  Application Receipt Date(s): September 22, 2022
• Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
  (RFA-CA-22-004)
  National Cancer Institute
  Application Receipt Date(s): September 22, 2022
• Renewal - Cooperative Agreement to Support the Joint Institute for Food Safety and Applied Nutrition, JIFSAN (U01) Clinical Trial Not Allowed
  (RFA-FD-22-004)
  Food and Drug Administration
  Application Receipt Date(s): January 7, 2022